University of Colorado, Denver: Neoplasms trials

The registry lists 21 Neoplasms studies with University of Colorado, Denver as lead sponsor. 4 are open to participants now and 3 have results posted.

Early Phase 1 1Phase 1 3Phase 2 2No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology TopicsRecruitingNCT07288476Not applicable
• Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood CancerRecruitingNCT05524610Not applicable
• Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer PatientsRecruitingNCT05515978Early Phase 1
• Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical TherapyEnrolling by invitationNCT03610906
• Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical TumorsTerminatedNCT03752203Not applicableResults posted
• Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph NodesCompletedNCT02700386Phase 2Results posted
• Phase II Trial for Large ER-Negative Breast CancersCompletedNCT01869192Phase 2Results posted
• BfedBwell Optimization PilotCompletedNCT06184256Not applicable
• Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer SurvivorsCompletedNCT05818462
• Integrative Health Interventions in Symptom Management of Pediatric PatientsCompletedNCT05594693
• Remote Temperature Data for Early Detection of Febrile NeutropeniaCompletedNCT05180838
• Evaluating a New Gonadotoxic Risk Stratification SystemWithdrawnNCT05052632
• Virtual Exercise Program to Reduce Cancer Related FatigueActive, not recruitingNCT04533165Not applicable
• Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL)CompletedNCT04240808Phase 1
• Psychosocial Intervention in Latino Patients with Advanced CancerCompletedNCT03763032Not applicable
• Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid TumorsWithdrawnNCT03496519Phase 1
• Biomarkers of Immune-Related ToxicityActive, not recruitingNCT03409016
• Medical Marijuana in the Pediatric Central Nervous System Tumor PopulationCompletedNCT03052738
• A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid TumorsCompletedNCT02596503Phase 1
• Fluorescein vs. iMRI in Resection of Malignant High Grade GliomaWithdrawnNCT02540135Not applicable
• Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation TherapyCompletedNCT01404728